Interstitial Lung Diseases in the Veterans Administration
1 other identifier
observational
3,000
1 country
1
Brief Summary
The primary objective of this research project is to describe the characteristics, diagnosis, management, and outcomes of patients with Interstitial Lung Disease (ILD) who received care at the Veteran's Administration Veterans Integrated Service Network (VISN) 6 Mid-Atlantic Health Care Network (VISN6) (includes North Carolina, Virginia and West Virginia) for up to 5 years.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for all trials
Started Jul 2016
Longer than P75 for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
June 19, 2015
CompletedFirst Posted
Study publicly available on registry
June 24, 2015
CompletedStudy Start
First participant enrolled
July 1, 2016
CompletedPrimary Completion
Last participant's last visit for primary outcome
November 1, 2022
CompletedStudy Completion
Last participant's last visit for all outcomes
June 1, 2023
CompletedJuly 26, 2022
July 1, 2022
6.3 years
June 19, 2015
July 25, 2022
Conditions
Keywords
Outcome Measures
Primary Outcomes (2)
Prevalence of Interstitial Lung Disease in the VISN6 Veterans Administration Patient Population
up to 5 years
Prevalence of Idiopathic Pulmonary Fibrosis in the VISN6 Veterans Administration Patient Population
up to 5 years
Secondary Outcomes (3)
Accuracy of ICD-9 Codes for diagnosis of Interstitial Lung Disease
up to 5 years
Frequency of ICD-9 code diagnosis of Interstitial Lung Disease and clinic consultation with a pulmonary provider
up to 5 years
Prevalence of Co-morbid Diabetes Mellitus with Interstitial Lung Disease
up to five years
Study Arms (1)
Interstitial Lung Disease
Patients will be identified from a specified 5 year period based on an International Classification of Diseases-9 (ICD-9) code diagnosis of Interstitial Lung disease (515) or Idiopathic Pulmonary Fibrosis (516.3). The patients will be obtained from the records of the Veterans Integrated Service Network (VISN) 6: VA Mid-Atlantic Health Care Network.
Eligibility Criteria
All adults with encounters at any VISN6 healthcare facility during specified time period
You may qualify if:
- Interstitial Lung Disease (ILD) ICD-9 code diagnosis 515.0 or 516.3
You may not qualify if:
- Inadequate documentation of patient receiving care for ILD in the health records
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Robert Tighelead
- Durham VA Medical Centercollaborator
- Boehringer Ingelheimcollaborator
Study Sites (1)
Durham VA Medical Center
Durham, North Carolina, 27705, United States
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Robert M Tighe, MD
Duke University Department of Medicine and Durham VA Medical Center
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- RETROSPECTIVE
- Sponsor Type
- FED
- Responsible Party
- SPONSOR INVESTIGATOR
- PI Title
- Staff Physician
Study Record Dates
First Submitted
June 19, 2015
First Posted
June 24, 2015
Study Start
July 1, 2016
Primary Completion
November 1, 2022
Study Completion
June 1, 2023
Last Updated
July 26, 2022
Record last verified: 2022-07